Replies to post #100965 on Ayala Pharmaceuticals Inc (ADXS)

[raja48185]

As many others, I'm not clear on the status of ADXS/PSA trial. What's the next step? Are they just waiting for data to "mature" or will this trial be discontinued similar to other non-NEO/HOT trials? Will Merck ever partner this program and fund the trial to take it to the finish line? I'd like to see KEYNOTE-046 on the Merck's Wall of Fame:

Do not fall for any of the half truths in the presentation.

Last year the target was to have 5 HOT trials up and running by end of 2019 (2 by end of 2018 and then another 3 by end of 2019)

If you go back to the previous presentation of March 2019, 2 more HOT Trials were planned by EOY.

ADXS-HOT Prostate•IND Submission1H 2019
ADXS-HOT Bladder•IND Submission2H 2019

See Slide 29

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=147456063

Now as per the latest presentation there is only one.

ADXS-504 HOT Prostate• IND Submission2H 2019
ADXS-506 HOT Bladder• IND Submission1H 2020

See Slide 22

https://www.advaxis.com/wp-content/uploads/2019/03/Corporate_Presentation_-_March_2019.pdf


Also data read out that was supposed to happen in 1H 2019 is now 2H 2019 for ADXS-503 HOT NSCLC; same goes for IST for Head and Neck Cancer ADXS-HPV (axalimogenefilolisbac)



By EOY, no surprises if there is none under HOT and everything is shifted to 2020. These guys will take their salary and be happy. Ken Berlin making close to 42K per month for doing nothing and using perks and free coffee/snacks to boot.